Khiari Houyem, Arfaoui Emna, Mahjoub Najet, Henchiri Soumaya, Sliti Alyssa, Hsairi Mohamed
Department of Epidemiology and Biostatistics, Salah Azaiz Institute of Cancer, Tunis, Tunisia.
Department of Oncology, Jendouba Hospital, Tunisia.
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4359-4369. doi: 10.31557/APJCP.2024.25.12.4359.
Cancer is a major cause of morbidity and mortality in Tunisia. The objectives of our study were to estimate the incidence level of the main cancer sites in Northern Tunisia in 2023 and to dress projections till 2040.
The population based cancer registry database of northern Tunisia was the source of cases of this study. This registry uses the active method to collect data from all health services that cover cancer patients of both public and private sectors. Incidence rate projections were established using the age-period-cohort model.
In 2023, according to our estimations, age standardized incidence rate (ASR) including skin cancers other than melanoma was of 165.9 /100,000 in males and 141.4/100,000 in females. In men, the five most common cancer locations (apart from the skin) were: lung with an ASR of 37.6/100,000 habitant, colorectal (29.4/100,000), bladder (24.1/100,000), prostate (15.2/100,000) and stomach (6.0/100,000). Concerning females, the top five locations (apart from the skin) were: breast (55.4/100,000), colorectal (23.0/100,000), corpus uteri (9.3/100,000), thyroid (9.0/100,000) and lung (5.8/100,000). By 2040, the incidence rates of colorectal cancer would reach more than the double in both genders. The ASR of lung and bladder cancers in males would be increasing; however, that of stomach cancer would be stable next decades. In females, while incidence rates of breast, thyroid and corpus uteri cancers would reach more than the double in 2040, cervical cancer incidence is expected to be stable next decades.
Cancer incidence level in Northern Tunisia place the country in an intermediate level and projections seem to be worrying. Strengthening prevention, screening and early diagnosis are strongly recommended.
癌症是突尼斯发病和死亡的主要原因。我们研究的目的是估计2023年突尼斯北部主要癌症部位的发病率水平,并做出到2040年的预测。
突尼斯北部基于人群的癌症登记数据库是本研究的病例来源。该登记处采用主动方法从覆盖公共和私营部门癌症患者的所有医疗服务机构收集数据。发病率预测采用年龄-时期-队列模型建立。
2023年,根据我们的估计,包括非黑色素瘤皮肤癌在内的年龄标准化发病率(ASR)在男性中为165.9/10万,在女性中为141.4/10万。在男性中,五个最常见的癌症部位(不包括皮肤)是:肺癌,ASR为37.6/10万居民,结直肠癌(29.4/10万),膀胱癌(24.1/10万),前列腺癌(15.2/10万)和胃癌(6.0/10万)。对于女性,前五个部位(不包括皮肤)是:乳腺癌(55.4/10万),结直肠癌(23.0/10万),子宫体癌(9.3/10万),甲状腺癌(9.0/10万)和肺癌(5.8/10万)。到2040年,结直肠癌的发病率在两性中都将达到两倍以上。男性肺癌和膀胱癌的ASR将上升;然而,未来几十年胃癌的ASR将保持稳定。在女性中,虽然乳腺癌、甲状腺癌和子宫体癌的发病率在2040年将达到两倍以上,但宫颈癌的发病率预计在未来几十年将保持稳定。
突尼斯北部的癌症发病率水平使该国处于中等水平,预测结果似乎令人担忧。强烈建议加强预防、筛查和早期诊断。